Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Clone Algo Technologies Inc. (OTC: CATI).

Full DD Report for CATI

You must become a subscriber to view this report.

Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CATI.

About Clone Algo Technologies Inc. (OTC: CATI)

Logo for Clone Algo Technologies Inc. (OTC: CATI)

We plan to be in the business of arranging medical, mobility, companion and associated services for senior citizens with medical and/or physical conditions that require or may require specialized accommodation


Contact Information



Current Management

  • Niraj Goel / Founder
  • Rajita Maitra / IR
  • Oksana Murarova / Treasurer, Secretary
  • Oksana Murarova /

Current Share Structure

  • Market Cap: $470,787,000 - 05/11/2018
  • Authorized: 3,000,000,000 - 11/05/2014
  • Issue and Outstanding: 94,157,400 - 03/23/2015


Recent Filings from (OTC: CATI)

Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: October, 30 2015



Daily Technical Chart for (OTC: CATI)

Daily Technical Chart for (OTC: CATI)

Stay tuned for daily updates and more on (OTC: CATI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CATI)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

OTC Report



Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CATI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CATI and does not buy, sell, or trade any shares of CATI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: